Table 2.
Variables associated with overall survival in univariate analyses for the entire study population.
Independent variables | Median OS | P value |
Age, yrs | <.001 | |
31–69 | 9.00 (7.74–10.26) | |
70–79 | 8.00 (5.34–10.66) | |
80–97 | 4.00 (2.09–5.91) | |
Sex | .409 | |
Female | 7.00 (5.56–8.44) | |
Male | 7.00 (5.68–8.32) | |
Race | .307 | |
Black | 5.00 (2.76–7.24) | |
Other | 10.00 (6.56–13.44) | |
White | 8.00 (7.01–8.99) | |
SEER historic stage | <.001 | |
Distant | 5.00 (3.74–6.26) | |
Localize | 14.00 (10.08–17.92) | |
Regional | 12.00 (9.08–14.92) | |
Primary site | .046 | |
Lower t | 8.00 (6.57–9.43) | |
Middle | 9.00 (7.68–10.32) | |
Overlap | 4.00 (2.62–5.38) | |
Upper t | 9.00 (7.09–10.91) | |
Surgery | .022 | |
No | 7.00 (6.00–8.00) | |
Yes | 14.00 (8.81–19.19) | |
Radiotherapy | <.001 | |
No | 5.00 (3.51–6.49) | |
Yes | 10.00 (8.34–11.66) | |
Chemotherapy | <.001 | |
No | 2.00 (1.45–2.55) | |
Yes | 11.00 (9.86–12.14) |